Brief Reports
Copyright ©The Author(s) 2004.
World J Gastroenterol. Nov 1, 2004; 10(21): 3225-3229
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3225
Table 2 Association of PTEN and VEGF expression and MVD with clinicopathologic profiles in gastric cancer (mean ± SD)
VariablesnPTENVEGFMVD
Age (yr)
≤ 35222.64 ± 1.812.77 ± 1.9646.23 ± 17.61
>35480.83 ± 1.33b3.02 ± 1.7649.20 ± 20.05
Gender
Male561.32 ± 1.693.00 ± 1.9148.45 ± 20.39
Female141.71 ± 1.822.71 ± 1.7347.54 ± 12.72
Differentiation
Well181.56 ± 1.823.33 ± 1.8845.94 ± 17.08
Poor521.35 ± 1.692.81 ± 1.8649.07 ± 20.72
Invasion depth
T182.50 ± 1.731.5 ± 1.9127.94 ± 12.1
≥ T2621.26 ± 1.69a3.13 ± 1.82a50.9 ± 19.31b
< T3381.47 ± 1.812.08 ± 1.2039.6 ± 16.6
≥ T3321.31 ± 1.663.97 ± 1.15a58.6 ± 18.9b
LN metastasis
Positive460.87 ± 1.363.57 ± 1.7753.9 ± 18.2
Negative242.42 ± 1.93b1.74 ± 2.07a37.5 ± 19.3b
TNM Stage
I + II361.83 ± 1.812.51 ± 1.2939.6 ± 18.3
III + IV340.97 ± 1.553.41 ± 1.18b57.5 ± 17.7b